Showing results (621-630 of 776) with videos related to
Sort By:
Pageof 78
Journal of Drugs in Dermatology : JDD|February 6, 2025
A Review of the Safety and Efficacy of Deucravacitinib for Plaque Psoriasis: An Expert Consensus PanelMilaan Shah, Joshua Burshtein, Danny Zakria, et al.The New England Journal of Medicine|November 25, 2003
A novel targeted T-cell modulator, efalizumab, for plaque psoriasisMark Lebwohl, Stephen K Tyring, Tiffani K Hamilton, et al.Dermatology and Therapy|February 10, 2024
The Efficacy and Safety of Bimekizumab for Plaque Psoriasis: An Expert Consensus PanelJoshua Burshtein, Milaan Shah, Danny Zakria, et al.Journal of Drugs in Dermatology : JDD|May 6, 2024
Patient- and Clinician-Reported Outcomes for Tirbanibulin in Actinic Keratosis in Clinical Practice Across the United States (PROAK)Todd Schlesinger, Leon Kircik, Mark Lebwohl, et al.JAMA Dermatology|April 6, 2013
Association of pediatric psoriasis severity with excess and central adiposity: an international cross-sectional studyAmy S Paller, Katherine Mercy, Mary J Kwasny, et al.Journal of the American Academy of Dermatology|May 8, 2003
Tazarotene cream in the treatment of psoriasis: Two multicenter, double-blind, randomized, vehicle-controlled studies of the safety and efficacy of tazarotene creams 0.05% and 0.1% applied once daily for 12 weeksGerald D Weinstein, John Y M Koo, Gerald G Krueger, et al.Journal of the American Academy of Dermatology|November 6, 2017
Depressive symptoms, depression, and the effect of biologic therapy among patients in Psoriasis Longitudinal Assessment and Registry (PSOLAR)Bruce Strober, Melinda Gooderham, Elke M G J de Jong, et al.Journal of Drugs in Dermatology : JDD|January 22, 2015
Safety observations in 12095 patients with psoriasis enrolled in an international registry (PSOLAR): experience with infliximab and other systemic and biologic therapiesAlice B Gottlieb, Robert E Kalb, Richard G Langley, et al.Journal of Drugs in Dermatology : JDD|August 16, 2021
Advances and Considerations in the Management of Actinic Keratosis: An Expert Consensus Panel ReportJames Del Rosso, April W Armstrong, Brian Berman, et al.The Journal of Dermatological Treatment|August 30, 2016
Eczema as an adverse effect of anti-TNFα therapy in psoriasis and other Th1-mediated diseases: a reviewMio Nakamura, Kristina Lee, Rasnik Singh, et al.Pageof 78